Click for best price
Postpemic Era Biosimilars/followonbiologics Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Post-pandemic Era-Global Biosimilars/follow-on-biologics Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate?, which aims to sort out the development status and trends of the Biosimilars/follow-on-biologics industry at home and abroad, estimate the overall market scale of the Biosimilars/follow-on-biologics industry and the market share of major countries, Biosimilars/follow-on-biologics industry, and study and judge the downstream market demand of Biosimilars/follow-on-biologics through systematic research, Analyze the competition pattern of Biosimilars/follow-on-biologics, so as to help solve the pain points of various stakeholders in Biosimilars/follow-on-biologics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Biosimilars/follow-on-biologics Market by Research Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Biosimilars/follow-on-biologics Market?
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Major Type of Biosimilars/follow-on-biologics Covered in Research report:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Application Segments Covered in Research Market
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
Post-pandemic Era-Global Biosimilars/follow-on-biologics Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
87 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Post-pandemic Era-Global Biosimilars/follow-on-biologics Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Human growth hormone -Product Introduction and Major Company
1.1.2 Erythropoietin -Product Introduction and Major Company
1.1.3 Monoclonal antibodies -Product Introduction and Major Company
1.1.4 Insulin -Product Introduction and Major Company
1.1.5 Interferon -Product Introduction and Major Company
1.1.6 Granulocyte-Colony Stimulating Factor -Product Introduction and Major Company
1.1.7 Others -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Biosimilars/follow-on-biologics Market Assessment by Type
3.1 Global Biosimilars/follow-on-biologics Sales by Type (2018-2028)
3.2 Global Biosimilars/follow-on-biologics Revenue by Type (2018-2028)
3.3 North America Biosimilars/follow-on-biologics Sales and Revenue by Type (2018-2028)
3.4 Asia Biosimilars/follow-on-biologics Sales and Revenue by Type (2018-2028)
3.5 Europe Biosimilars/follow-on-biologics Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Biosimilars/follow-on-biologics Sales and Revenue by Type (2018-2028)
3.7 South America Biosimilars/follow-on-biologics Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Biosimilars/follow-on-biologics Market Assessment by Application
4.1 Global Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Biosimilars/follow-on-biologics Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
6.3 India Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
7.3 France Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Biosimilars/follow-on-biologics Sales, Revenue and Growth Rate (2018-2028)
10 Global Biosimilars/follow-on-biologics Average Price Trend
10.1 Market Price for Each Type of Biosimilars/follow-on-biologics in North America (2018-2028)
10.2 Market Price for Each Type of Biosimilars/follow-on-biologics in Asia (2018-2028)
10.3 Market Price for Each Type of Biosimilars/follow-on-biologics in Europe (2018-2028)
10.4 Market Price for Each Type of Biosimilars/follow-on-biologics in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Biosimilars/follow-on-biologics in South America (2018-2028)
11 Value Chain
11.1 Biosimilars/follow-on-biologics Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Biosimilars/follow-on-biologics Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Biosimilars/follow-on-biologics Market, Competitive Analysis
12.1 Novartis (Sandoz)
12.1.1 Novartis (Sandoz) Company Profiles and Company News
12.1.2 Novartis (Sandoz) Product Introduction
12.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Synthon Pharmaceuticals
12.2.1 Synthon Pharmaceuticals Company Profiles and Company News
12.2.2 Synthon Pharmaceuticals Product Introduction
12.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Teva Pharmaceutical Industries
12.3.1 Teva Pharmaceutical Industries Company Profiles and Company News
12.3.2 Teva Pharmaceutical Industries Product Introduction
12.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 LG Life Sciences
12.4.1 LG Life Sciences Company Profiles and Company News
12.4.2 LG Life Sciences Product Introduction
12.4.3 LG Life Sciences Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Genentech (Roche)
12.5.1 Celltrion Biocon Company Profiles and Company News
12.5.2 Celltrion Biocon Product Introduction
12.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Hospira
12.6.1 Hospira Company Profiles and Company News
12.6.2 Hospira Product Introduction
12.6.3 Hospira Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Merck Serono (Merck)
12.7.1 Merck Serono (Merck) Company Profiles and Company News
12.7.2 Merck Serono (Merck) Product Introduction
12.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Biogen idec
12.8.1 Biogen idec Company Profiles and Company News
12.8.2 Biogen idec Product Introduction
12.8.3 Biogen idec Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Genentech (Roche)
12.9.1 Genentech (Roche) Company Profiles and Company News
12.9.2 Genentech (Roche) Product Introduction
12.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
13 Global Biosimilars/follow-on-biologics Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Biosimilars/follow-on-biologics Market
13.2 Concentration Ratio (CR5) of Global Biosimilars/follow-on-biologics Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Biosimilars/follow-on-biologics Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Biosimilars/follow-on-biologics Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure Global Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Biosimilars/follow-on-biologics Sales Market Share (%) by Type (2019 -2020)
Table Global Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure Global Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Biosimilars/follow-on-biologics Revenue Market Share (%) by Type (2019-2020)
Figure North America Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure North America Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure North America Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure Asia Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure Asia Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure Europe Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure Europe Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Biosimilars/follow-on-biologics Sales (K Unit) by Type (2018-2028)
Figure South America Biosimilars/follow-on-biologics Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2018-2028)
Figure South America Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure North America Biosimilars/follow-on-biologics Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Biosimilars/follow-on-biologics Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure Asia Biosimilars/follow-on-biologics Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Biosimilars/follow-on-biologics Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure Europe Biosimilars/follow-on-biologics Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Biosimilars/follow-on-biologics Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure Middle East & Africa Biosimilars/follow-on-biologics Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Biosimilars/follow-on-biologics Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Figure South America Biosimilars/follow-on-biologics Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Biosimilars/follow-on-biologics Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Biosimilars/follow-on-biologics Different Application Field Consumption (K Unit)
Table US Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Biosimilars/follow-on-biologics Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in China
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in EU
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in USA
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Japan
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in India
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in South America
Figure Value Chain Structure of Biosimilars/follow-on-biologics
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Biosimilars/follow-on-biologics
Figure Cost Structure of Biosimilars/follow-on-biologics in 2020
Table Distributors/Traders List
Table Novartis (Sandoz) Profiles
Table Novartis (Sandoz) Biosimilars/follow-on-biologics Product Introduction
Figure Novartis (Sandoz) Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Novartis (Sandoz) SWOT Analysis
Table Synthon Pharmaceuticals Profiles
Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Introduction
Figure Synthon Pharmaceuticals Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Synthon Pharmaceuticals SWOT Analysis
Table Teva Pharmaceutical Industries Profiles
Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Introduction
Figure Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Teva Pharmaceutical Industries SWOT Analysis
Table LG Life Sciences Profiles
Table LG Life Sciences Biosimilars/follow-on-biologics Product Introduction
Figure LG Life Sciences Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure LG Life Sciences SWOT Analysis
Table Celltrion Biocon Profiles
Table Celltrion Biocon Biosimilars/follow-on-biologics Product Introduction
Figure Celltrion Biocon Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Celltrion Biocon SWOT Analysis
Table Hospira Profiles
Table Hospira Biosimilars/follow-on-biologics Product Introduction
Figure Hospira Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Hospira SWOT Analysis
Table Merck Serono (Merck) Profiles
Table Merck Serono (Merck) Biosimilars/follow-on-biologics Product Introduction
Figure Merck Serono (Merck) Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Merck Serono (Merck) SWOT Analysis
Table Biogen idec Profiles
Table Biogen idec Biosimilars/follow-on-biologics Product Introduction
Figure Biogen idec Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Biogen idec SWOT Analysis
Table Genentech (Roche) Profiles
Table Genentech (Roche) Biosimilars/follow-on-biologics Product Introduction
Figure Genentech (Roche) Biosimilars/follow-on-biologics Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Genentech (Roche) SWOT Analysis
